Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US

JAMA
November 17, 2020, Vol 324, No. 19, Pages 1925-2006
https://jamanetwork.com/journals/jama/currentissue

 

Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US
Grace M. Lee, MD, MPH; José R. Romero, MD; Beth P. Bell, MD, MPH
free access has active quiz
JAMA. 2020;324(19):1937-1938. doi:10.1001/jama.2020.19692
This Viewpoint reviews systems in place to monitor postlicensure vaccine safety, and recommends harmonizing end points and protocols across vaccine trials and surveillance systems to enable timely identification and reliable evaluation of potential adverse events.